`
`
`
`
`
`
`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF DELAWARE
`
`
`
`
`
`
` C.A. No. 18-924-CFC-SRF
`
`
`
`
`
`
`GENENTECH, INC.,
`
`v.
`
`AMGEN INC.,
`
`Plaintiff,
`
`Defendant.
`
`
`
`
`JOINT MOTION FOR TELECONFERENCE
`
`Plaintiff Genentech, Inc. and Defendant Amgen Inc. by and through their
`
`undersigned counsel, respectfully move this Court to schedule a teleconference to
`
`address outstanding disputes regarding the following discovery matters:
`
`1) Amgen’s redaction of all references to and information about its other
`
`products other than Kanjinti (its trastuzumab biosimilar), including
`
`Mvasi (its bevacizumab biosimilar), from its documents; and
`
`2) The scope of document collection and production of email in
`
`connection with the damages discovery portion of this matter.
`
`The following attorneys, including at least one Delaware Counsel and at
`
`least one Lead Counsel per party, participated in a verbal meet-and-confer by
`
`telephone on November 25, 2019.
`
`Genentech’s Delaware Counsel: Daniel M. Silver, Esq., McCarter &
`English, LLP
`
`
`M E 1 3 2 1 9 9 6 2 6 v. 1
`
`
`
`Case 1:18-cv-00924-CFC-SRF Document 468 Filed 12/19/19 Page 2 of 3 PageID #: 33415
`
`
`
`Genentech’s Lead Counsel: Eric Wiener, Esq. and Henry Huttinger, Esq.,
`Durie Tangri LLP, Sonal Mehta, Esq. and Andrew Danford, Esq., Wilmer Cutler
`Pickering Hale and Dorr LLP
`
`Amgen’s Delaware Counsel: Neal Belgam, Esq., Smith, Katzenstein &
`Jenkins LLP
`
`Amgen’s Lead Counsel: Orion Armon, Esq., Cooley LLP
`
`The following attorneys, including at least one Delaware Counsel and at
`
`least one Lead Counsel per party, participated in a second verbal meet-and-confer
`
`by telephone on December 11, 2019.
`
`Genentech’s Delaware Counsel: Daniel M. Silver and Alexandra Joyce,
`Esq., McCarter & English, LLP
`
`Genentech’s Lead Counsel: Eric Wiener, Esq. and Henry Huttinger, Esq.,
`Durie Tangri LLP, Andrew Danford, Esq., Wilmer Cutler Pickering Hale and Dorr
`LLP
`
`Amgen’s Delaware Counsel: Neal Belgam, Esq., Smith, Katzenstein &
`Jenkins LLP
`
`Amgen’s Lead Counsel: Orion Armon, Esq. and Priya Arora, Cooley LLP.
`
`
`
`The parties are available for a teleconference on the following dates: January
`
`6, January 7, and January 8, 2020.
`
`
`
`
`
`
`
`
`
`M E 1 3 2 1 9 9 6 2 6 v. 1
`
`2
`
`
`
`Case 1:18-cv-00924-CFC-SRF Document 468 Filed 12/19/19 Page 3 of 3 PageID #: 33416
`
`
`
`Dated: December 19, 2019
`
`
`
`
`
`MCCARTER & ENGLISH, LLP
`
`
`
`/s/ Daniel M. Silver
`Michael P. Kelly (#2295)
`Daniel M. Silver (#4758)
`Alexandra M. Joyce (#6423)
`Renaissance Centre
`405 N. King Street, 8th Floor
`Wilmington, DE 19801
`(302) 984-6300
`mkelly@mccarter.com
`dsilver@mccarter.com
`ajoyce@mccarter.com
`
`Attorneys for Plaintiff Genentech, Inc.
`
`
`
`
`
`
`
`
`
`SMITH KATZENSTEIN & JENKINS
`LLP
`
`/s/ Neal C. Belgam
`Neal C. Belgam (#2721)
`Eve H. Ormerod (#5369)
`Jennifer M. Rutter (#6200)
`1000 West Street, Suite 1501
`Wilmington, DE 19801
`(302) 652-8400
`nbelgam@skjlaw.com
`eormerod@skjlaw.com
`jrutter@skjlaw.com
`
`Attorneys for Defendant Amgen Inc.
`
`
`
`
`
`
`
`
`
`
`SO ORDERED this _____ day of _________________, 2019.
`
`
`
`
`
`
`
`
`
`
`
`
`
`______________________________
`United States Magistrate Judge
`
`M E 1 3 2 1 9 9 6 2 6 v. 1
`
`3
`
`